NO991376L - Farmas°ytiske sammensetninger inneholdende et brusende syre-base par - Google Patents

Farmas°ytiske sammensetninger inneholdende et brusende syre-base par

Info

Publication number
NO991376L
NO991376L NO991376A NO991376A NO991376L NO 991376 L NO991376 L NO 991376L NO 991376 A NO991376 A NO 991376A NO 991376 A NO991376 A NO 991376A NO 991376 L NO991376 L NO 991376L
Authority
NO
Norway
Prior art keywords
effervescent
compositions containing
base pair
surface compositions
effervescent acid
Prior art date
Application number
NO991376A
Other languages
English (en)
Other versions
NO326639B1 (no
NO991376D0 (no
Inventor
Paolo Chiesi
Paolo Ventura
Rosa Mezzadri
Gaetano Brambilla
Daniela Acerbi
Original Assignee
Chiesi Farma Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiesi Farma Spa filed Critical Chiesi Farma Spa
Publication of NO991376D0 publication Critical patent/NO991376D0/no
Publication of NO991376L publication Critical patent/NO991376L/no
Publication of NO326639B1 publication Critical patent/NO326639B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/10—Expectorants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Psychology (AREA)
  • Pulmonology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO19991376A 1997-07-23 1999-03-22 Farmasoytiske sammensetninger inneholdende et brusende syre-base par NO326639B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT97MI001746A IT1293764B1 (it) 1997-07-23 1997-07-23 Composizioni farmaceutiche sotto forma di compresse effervescenti contenenti un principio attivo instabile in presenza di acqua
PCT/EP1998/004517 WO1999004765A2 (en) 1997-07-23 1998-07-23 Pharmaceutical compositions containing an effervescent acid-base couple

Publications (3)

Publication Number Publication Date
NO991376D0 NO991376D0 (no) 1999-03-22
NO991376L true NO991376L (no) 1999-05-25
NO326639B1 NO326639B1 (no) 2009-01-26

Family

ID=11377613

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19991376A NO326639B1 (no) 1997-07-23 1999-03-22 Farmasoytiske sammensetninger inneholdende et brusende syre-base par

Country Status (27)

Country Link
US (1) US6284272B1 (no)
EP (1) EP1003486B1 (no)
JP (1) JP4801255B2 (no)
KR (1) KR100528141B1 (no)
CN (1) CN1138535C (no)
AT (1) ATE232092T1 (no)
AU (1) AU743186B2 (no)
BG (1) BG64074B1 (no)
BR (1) BR9801335B1 (no)
CZ (1) CZ296221B6 (no)
DE (1) DE69811236T2 (no)
DK (1) DK1003486T3 (no)
EA (1) EA002608B1 (no)
ES (1) ES2191960T3 (no)
HK (1) HK1029525A1 (no)
HU (1) HU226115B1 (no)
IL (1) IL134166A (no)
IT (1) IT1293764B1 (no)
NO (1) NO326639B1 (no)
NZ (1) NZ502479A (no)
OA (1) OA10999A (no)
PL (1) PL199164B1 (no)
PT (1) PT1003486E (no)
SI (1) SI1003486T1 (no)
SK (1) SK284551B6 (no)
TR (1) TR199900675T1 (no)
WO (1) WO1999004765A2 (no)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040151768A1 (en) * 1997-07-23 2004-08-05 Chiesi Farmaceutici S.P.A. Pharmaceutical compositions containing an effervescent acid-base couple
FR2786395A1 (fr) * 1998-12-01 2000-06-02 Virbac Sa Compositions seches solubles en presence d'eau et evitant la reaction de maillard a l'etat sec, leur preparation et leurs applications
CA2378525A1 (en) * 1999-07-02 2001-01-11 Sca Lohnherstellungs Ag A solid formulation of glucosamine sulphate
WO2001010405A1 (en) * 1999-08-04 2001-02-15 Ranbaxy Laboratories Limited Hydrodynamically balanced oral drug delivery system
IN190018B (no) * 1999-09-28 2003-05-31 Panacea Biotec Ltd
GB0006897D0 (en) * 2000-03-23 2000-05-10 Smithkline Beecham Plc Medicaments
NZ524124A (en) * 2000-08-18 2004-09-24 Pharmacia Corp Rapidly disintegrating oral formulation of a cyclooxygenase-2 inhibitor
CN1638739A (zh) * 2000-08-18 2005-07-13 法玛西雅厄普约翰美国公司 治疗成瘾性障碍的化合物
US6531153B2 (en) 2001-05-29 2003-03-11 Drugtech Corporation Composition with sustained release of levodopa and carbidopa
US6762153B2 (en) * 2001-10-18 2004-07-13 Rohm And Haas Company Delivery system for cyclopropenes
US20030091627A1 (en) * 2001-10-31 2003-05-15 Vinay Sharma Rate-controlled delivery of macrolides
KR100456273B1 (ko) * 2001-11-16 2004-11-10 김용년 산과 반응하여 일정 속도로 이산화탄소를 발생시킬 수있는 고상 제제 및 그의 제조 방법
ES2448501T3 (es) 2002-03-06 2014-03-14 Effrx Pharmaceuticals Sa Composiciones efervescentes que comprenden bisfosfonatos
US7488496B2 (en) * 2002-03-06 2009-02-10 Christer Rosen Effervescent compositions comprising bisphosphonates and methods related thereto
BG730Y1 (bg) * 2003-03-20 2005-04-30 Владимир НАЙДЕНОВ Ефервесцентна лекарствена форма
CN100445263C (zh) * 2003-04-24 2008-12-24 四川大学 甘氨酸钠碳酸盐的微波合成方法
FR2876911B1 (fr) * 2004-10-21 2007-04-13 Pierre Fabre Medicament Sa Complexe comprenant du piroxicam, une cyclodextrine et de l'arginine
EP1729813B1 (fr) 2004-04-01 2011-04-06 Pierre Fabre Medicament Complexes d'inclusions comprenant du piroxicam, une cyclodextrine et l'arginine
US8216610B2 (en) * 2004-05-28 2012-07-10 Imaginot Pty Ltd. Oral paracetamol formulations
AU2005247048B2 (en) * 2004-05-28 2007-12-13 Imaginot Pty Ltd Oral therapeutic compound delivery system
EP1901720A2 (en) * 2005-06-23 2008-03-26 Spherics, Inc. Improved dosage forms for movement disorder treatment
CN100341488C (zh) * 2005-11-22 2007-10-10 瑞普（保定）生物药业有限公司 一种饮水免疫泡腾片及其制备方法
EP3449928A1 (en) * 2005-11-28 2019-03-06 Imaginot Pty Ltd. Oral therapeutic compound delivery system
US20080131492A1 (en) * 2006-06-23 2008-06-05 Spherics, Inc. Dosage forms for movement disorder treatment
WO2008079404A2 (en) * 2006-12-22 2008-07-03 Combinatorx, Incorporated Pharmaceutical compositions for treatment of parkinson's disease and related disorders
ES2745438T3 (es) * 2007-05-08 2020-03-02 Hercules Llc Formulación robusta de comprimidos de desintegración rápida
AU2008343787B2 (en) 2007-12-28 2014-01-30 Impax Laboratories, Llc Controlled release formulations of levodopa and uses thereof
EP2309988B1 (en) 2008-07-21 2015-11-25 SI Group, Inc. High content sodium ibuprofen granules, their preparation and their use in preparing non-effervescent solid dosage forms
US9629809B2 (en) 2008-07-21 2017-04-25 Si Group, Inc. High content sodium ibuprofen granules, their preparation and their use in preparing non-effervescent solid dosage forms
CA2792733C (en) * 2010-03-13 2015-06-02 Eastpond Laboratories Limited Fat-binding compositions comprising .alpha.- or .beta.-cyclodextrin
CN101836951B (zh) * 2010-05-20 2013-06-05 山东达因海洋生物制药股份有限公司 一种含盐酸氨溴索的口服溶液及其制备方法
CN102322123B (zh) * 2011-06-30 2013-09-18 德清艺玛工艺装饰有限公司 一种仿大理石泡沫装饰材料
CN102398378A (zh) * 2011-11-03 2012-04-04 北京华禧联合科技发展有限公司 镀铬冲模在硫酸氢氯吡格雷片制备过程中的应用
MX2015007571A (es) * 2012-12-14 2016-04-15 Si Group Inc Granulos con alto contenido de ibuprofeno sodico, su preparacion y su uso en la preparacion de formas de dosis solidas no efervescentes.
US10987313B2 (en) 2013-10-07 2021-04-27 Impax Laboratories, Llc Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereof
US10098845B2 (en) 2013-10-07 2018-10-16 Impax Laboratories, Llc Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereof
EP2870961B1 (en) * 2013-11-06 2018-07-18 Sanovel Ilac Sanayi ve Ticaret A.S. Effervescent formulations of pramipexole
MA52122A (fr) 2018-03-02 2021-04-28 Chiesi Farm Spa Formulation pharmaceutique pour administration intraduodénale comprenant de la mélévodopa et de la carbidopa
US11986449B2 (en) 2020-12-22 2024-05-21 Amneal Pharmaceuticals Llc Levodopa dosing regimen

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1196033B (it) * 1984-02-22 1988-11-10 Chiesi Farma Spa Composto ad attivita' antiinfiammatoria ottenuto per complessazione con beta-ciclodestrina e relative formulazioni farmaceutiche
ATE76747T1 (de) * 1986-06-10 1992-06-15 Chiesi Farma Spa Levodopa-methyl-ester enthaltende pharmazeutische zusammensetzungen, ihre herstellung und therapeutische verwendungen.
CH675537A5 (no) * 1988-03-25 1990-10-15 Ciba Geigy Ag
DE3838431A1 (de) * 1988-11-12 1990-05-17 Bayer Ag Ibuprofen-brausezubereitungen
ATE108649T1 (de) * 1990-02-14 1994-08-15 Takeda Chemical Industries Ltd Brausemischung, deren herstellung sowie verwendung.
US5252341A (en) * 1990-07-16 1993-10-12 Degussa Aktiengesellschaft Tablets and granulates containing mesna as active substance
JP2910425B2 (ja) * 1992-06-17 1999-06-23 和光純薬工業株式会社 発泡性錠剤の新規な製造方法
JP3170139B2 (ja) * 1994-04-08 2001-05-28 エスエス製薬株式会社 発泡性錠剤
FR2733420B1 (fr) * 1995-04-28 1997-06-27 Sep Tarral Preparations pectiques utilisables comme support de medicament
DE69726879T2 (de) * 1996-05-17 2004-10-14 Merck & Co., Inc. Biphosphonat-formulierung mit brausewirkung

Also Published As

Publication number Publication date
JP2001510789A (ja) 2001-08-07
KR100528141B1 (ko) 2005-11-15
NO326639B1 (no) 2009-01-26
BG103253A (en) 1999-09-30
EA200000062A1 (ru) 2000-10-30
HUP0003897A2 (hu) 2001-08-28
CN1138535C (zh) 2004-02-18
DK1003486T3 (da) 2003-05-19
PL338502A1 (en) 2000-11-06
US6284272B1 (en) 2001-09-04
AU743186B2 (en) 2002-01-17
BR9801335B1 (pt) 2010-09-21
DE69811236D1 (de) 2003-03-13
BR9801335A (pt) 1999-05-04
ES2191960T3 (es) 2003-09-16
TR199900675T1 (xx) 1999-11-22
NZ502479A (en) 2002-02-01
NO991376D0 (no) 1999-03-22
IT1293764B1 (it) 1999-03-10
PT1003486E (pt) 2003-06-30
ATE232092T1 (de) 2003-02-15
EP1003486A2 (en) 2000-05-31
IL134166A0 (en) 2001-04-30
BG64074B1 (bg) 2003-12-31
IL134166A (en) 2005-08-31
EP1003486B1 (en) 2003-02-05
CZ296221B6 (cs) 2006-02-15
SK284551B6 (sk) 2005-06-02
WO1999004765A3 (en) 1999-06-10
ITMI971746A1 (it) 1999-01-23
CZ2000255A3 (cs) 2000-07-12
HUP0003897A3 (en) 2006-06-28
EA002608B1 (ru) 2002-06-27
OA10999A (en) 2001-11-07
CN1267215A (zh) 2000-09-20
PL199164B1 (pl) 2008-08-29
AU8977798A (en) 1999-02-16
DE69811236T2 (de) 2003-10-30
HK1029525A1 (en) 2001-04-06
HU226115B1 (en) 2008-04-28
SK922000A3 (en) 2000-07-11
WO1999004765A2 (en) 1999-02-04
JP4801255B2 (ja) 2011-10-26
SI1003486T1 (en) 2003-08-31
KR20010022140A (ko) 2001-03-15

Similar Documents

Publication Publication Date Title
NO991376D0 (no) Farmas°ytiske sammensetninger inneholdende et brusende syre-base par
DE69626117D1 (de) Orale pharmazeutische zusammensetzungen mit verzögerter freisetzung von reversiblen protonpumpen-inhibitoren
TR200101261T2 (tr) Uzun süreli salınımlı ranolazin formülasyonları.
NO20003196D0 (no) Umiddelbart smeltende doseringsformulering
EE03089B1 (et) Ibuprofeeni sisaldav kihisev ravimpreparaat ja selle valmistamise meetod
AR018829A1 (es) Formulaciones farmaceuticas solidas de rapida desintegracion, administrables via oral y procedimiento para prepararlos
DE69403656D1 (de) Stabile, orale und absorbierbare therapeutische zusammensetzungen von nadh und nadph
ID28510A (id) Formulasi oral yang baru untuk agonis atau antagonis 5-ht4
CA2106216A1 (en) Chewable antacid compositions
WO2002015933A3 (en) Combination comprising an at1-receptor antagonist and an insulin secretion enhancer or an insulin sensitiser
ATE291421T1 (de) Pharmazeutische, ramipril enthaltende brauseformulierung
CA2297673A1 (en) Pharmaceutical compositions containing an effervescent acid-base couple
CA2225628A1 (en) Oral pharmaceutical compositions with delayed release of reversible proton pump inhibitors
MY128958A (en) New oral formulation for 5-ht4 agonists or antagonists.

Legal Events

Date Code Title Description
MK1K Patent expired